Compare AU
Compare CETF vs. EDOC
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the FTSE China Top 50 (CETF) and the BetaShares Digital Health and Telemedicine ETF (EDOC). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
CETF | EDOC | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 30 | 10 |
Median incremental investment | $956.32 | $705.01 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,338.83 | $624.97 |
Average age group | > 35 | > 35 |
Key Summary
CETF | EDOC | |
|---|---|---|
Strategy | CETF.AX was created on 2015-06-26 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The Fund seeks to provide investors with access to a portfolio of the 50 largest companies in the mainland Chinese market. | EDOC.AX was created on 2022-03-30 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. The investment objective of the BetaShares Digital Health and Telemedicine ETF is to provide an investment return that aims to track the performance of the NASDAQ CTA Global Digital Health Index (the Index), before taking into account fees and expenses. |
Top 3 holdings | Kweichow Moutai Co Ltd Class A (11.64 %) Contemporary Amperex Technology Co Ltd Class A (7.23 %) China Merchants Bank Co Ltd Class A (4.76 %) | INSULET CORP (8.47 %) BOSTON SCIENTIFIC CORP (8.24 %) ABBOTT LABORATORIES (7.76 %) |
Top 3 industries | Financials (35.50 %) Consumer Staples (33.17 %) Industrials (15.44 %) | Health Care (75.06 %) Other (24.70 %) Consumer Staples (14.33 %) |
Top 3 countries | China (100.00 %) | United States (77.51 %) China (13.32 %) Japan (4.67 %) |
Management fee | 0.6 % | 0.67 % |
Key Summary
CETF | EDOC | |
|---|---|---|
Issuer | VanEck | BetaShares |
Tracking index | FTSE China A50 Index - CNY | Nasdaq CTA Global Digital Health Index - AUD - Benchmark TR Net |
Asset class | ETF | ETF |
Management fee | 0.6 % | 0.67 % |
Price | $58.21 | $10.33 |
Size | $34.649 million | $1.525 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 2.02 % | - % |
Market | ASX | ASX |
First listed date | 26/06/2015 | 29/03/2022 |
Purchase fee | $6.50 | $6.50 |
Community Stats
CETF | EDOC | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 30 | 10 |
Median incremental investment | $956.32 | $705.01 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,338.83 | $624.97 |
Average age group | > 35 | > 35 |
Pros and Cons
CETF | EDOC | |
|---|---|---|
Pros |
|
|
Cons |
|
|
CETF | EDOC |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |